DHT-OVA is a conjugate of DHT (Dihydrotestosterone) and OVA peptide. By conjugating the antigen with a protein adjuvant, the production of antigen-specific antibodies in vaccine models can be enhanced. The conjugate does not affect protein folding or disrupt linear epitopes, and it can enhance cross-presentation and the generation of antigen-specific T cells.
Target:
Biochemical Assay Reagents
Application Notes:
Biochemical Assay Reagents
* VAT and and shipping costs not included. Errors and price changes excepted
